logo

Continuous Glucose Monitoring (CGM) Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The continuous glucose monitoring (CGM) market is segmented by Component (Sensors, Durables (Receivers and Transmitter)), and Geography.

Home Industry Reports Healthcare Continuous Glucose Monitoring (CGM) Market - Growth, Trends, COVID-19 Impact, an ...

Continuous Glucose Monitoring (CGM) Market Snapshot

Continuous Glucose Monitoring (CGM) Market
Study Period: 2016- 2026
Base Year: 2020
Fastest Growing Market: North America
Largest Market: North America
CAGR: >14 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The Continuous Glucose Monitoring (CGM) Market is anticipated to register a CAGR of 14% during the forecast period. As per WHO data, approximately half of all mortality can be associated with high blood glucose levels, which occur before the age of 70 years. WHO also expects diabetes to be the seventh-leading cause of mortality by 2030. For patients reliant on insulin pumps or daily insulin injections, the CGM establishes itself to be an instrumental tool, which helps in the enhancement of glycemic balance without increasing the danger of fatal hypoglycemia. As studied in several clinical trials, diabetic patients with Type 1 diabetes mellitus (T1DM) using continuous glucose monitoring have shown to have better glycemic control, in comparison to when glucometer is used for routine self-monitoring blood glucose. The trend follows in children, as well as those who use a CGM on a regular basis. The results in these children show better-glycosylated hemoglobin (HbA1c) levels without an amplified frequency of hypoglycemia. The current CGM models approved administer glucose oxidase-based electrochemical subcutaneous sensors for the detection of glucose levels in the interstitial fluid. CGM devices can either retrospectively display the trends in the levels of blood glucose by downloading the data or give a real-time picture of glucose levels through receiver displays. Most of the real-time CGMs can offer an alert to patients, parents, or caregivers during actual or pending glycemic visits, to facilitate timely management of blood glucose.

Scope of the Report

The study offers a detailed analysis on the use of the Continuous Glucose Monitoring Market and also provides the market share, size, forecast, and industry overview.

Continuous Blood Glucose Monitoring
By Component (Value and Volume, 2016 - 2026)
Sensors
Durables (Receivers and Transmitter)
Geography (Value and Volume, 2016 - 2026)
North America
United States
By Component
Coronavirus Impact on CGM Devices
Canada
By Component
Coronavirus Impact on CGM Devices
Rest of North America
By Component
Coronavirus Impact on CGM Devices
Europe
France
By Component
Coronavirus Impact on CGM Devices
Germany
By Component
Coronavirus Impact on CGM Devices
Italy
By Component
Coronavirus Impact on CGM Devices
Spain
By Component
Coronavirus Impact on CGM Devices
United Kingdom
By Component
Coronavirus Impact on CGM Devices
Russia
By Component
Coronavirus Impact on CGM Devices
Rest of Europe
By Component
Coronavirus Impact on CGM Devices
Latin America
Mexico
By Component
Coronavirus Impact on CGM Devices
Brazil
By Component
Coronavirus Impact on CGM Devices
Rest of Latin America
By Component
Coronavirus Impact on CGM Devices
Asia-Pacific
Japan
By Component
Coronavirus Impact on CGM Devices
South Korea
By Component
Coronavirus Impact on CGM Devices
China
By Component
Coronavirus Impact on CGM Devices
India
By Component
Coronavirus Impact on CGM Devices
Australia
By Component
Coronavirus Impact on CGM Devices
Vietnam
By Component
Coronavirus Impact on CGM Devices
Malaysia
By Component
Coronavirus Impact on CGM Devices
Indonesia
By Component
Coronavirus Impact on CGM Devices
Philippines
By Component
Coronavirus Impact on CGM Devices
Thailand
By Component
Coronavirus Impact on CGM Devices
Rest of Asia-Pacific
By Component
Coronavirus Impact on CGM Devices
Middle-East and Africa
Saudi Arabia
By Component
Coronavirus Impact on CGM Devices
Iran
By Component
Coronavirus Impact on CGM Devices
Egypt
By Component
Coronavirus Impact on CGM Devices
Oman
By Component
Coronavirus Impact on CGM Devices
South Africa
By Component
Coronavirus Impact on CGM Devices
Rest of Middle-East and Africa
By Component
Coronavirus Impact on CGM Devices

Report scope can be customized per your requirements. Click here.

Key Market Trends

The market for CGM is on the rise

CGMs are used to provide a further descriptive representation of blood glucose patterns and tendencies than what can be achieved by conventional routine checking of glucose levels at set intervals. The current CGM devices can either retrospectively display the trends in the levels of blood glucose by downloading the data or give a real-time picture of glucose levels through receiver displays. Most of the real-time CGMs have the capability to offer an alert to patients, parents, or caregivers during actual or pending glycemic visits, to facilitate timely management of blood glucose. This factor, along with the fact that CGM devices are becoming cheaper with the advent of new technologies, like cell phone integration, is likely to drive the steady growth of the CGM market during the forecast period.

CGM revenue

North America will Maintain Dominance in the Market

In North America, the United States accounted for close to 93% of the market value in 2020. By 2026, the continuous glucose monitoring market in the United States is expected to be valued at more than USD 4.5 billion. The Continuous Glucose Monitoring Market in the US is anticipated to register a CAGR of more than 10% during the forecast period. It is imperative that the CGM devices be used alongside insulin pumps. As the trends show a higher number of diabetic patients using insulin pumps for diabetes management, it can be predicted that the number of units of CGM devices sold will also follow. As the trend shows a higher number of diabetic patients using insulin pumps for diabetes management, it can be predicted that the number of units of CGM devices sold will also follow a similar trend in the coming years. Abbott and Dexcom received FDA approval to use Continuous Glucose Monitoring in United States hospitals for Coronavirus-affected people. Dexcom began shipping CGMs to hospitals in April 2020 and plans to make 100,000 sensors to sell to hospitals at low-cost and planned to donate 10,000 phones and CGM readers to hospitals for scanning those sensors.

Region Share

Competitive Landscape

A major share of the market is held by CGM manufacturers that are concomitant with strategy-based M&A operations and are constantly entering new markets to generate new revenue streams and to boost existing ones. These measures taken by the market players will ensure a competitive marketplace, therefore, forcing the companies to experiment with more new technologies, to ensure uniqueness in their products. Also, one of the implications of the competition in the market is that it will ensure a constant decrease in the average selling price of the CGM units produced. The market is consolidated with few players accounting for a major share. Also, companies are collaborating to increase their technological know-how and to fasten the product development cycle.

Continuous Glucose Monitoring (CGM) Market

Recent Developments

In February 2020, Abbott and Insulet partnered to integrate next-generation glucose sensing and automated insulin delivery technologies for seamless diabetes care. The collaboration will combine Abbott's continuous glucose monitoring (CGM) technology with Insulet's Omnipod Horizon Automated Insulin Delivery System to offer an accurate, easy-to-use, integrated digital health platform.​ Abbott has also priced the new device substantially lower than its competitors, which will help the company to strengthen its position in the CGM market during the forecast period.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Drivers

    3. 4.3 Restraints

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Bargaining Power of Suppliers

      2. 4.4.2 Bargaining Power of Consumers

      3. 4.4.3 Threat of New Entrants

      4. 4.4.4 Threat of Substitute Products and Services

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. Market Segmentation

    1. 5.1 Continuous Blood Glucose Monitoring

      1. 5.1.1 By Component (Value and Volume, 2016 - 2026)

        1. 5.1.1.1 Sensors

        2. 5.1.1.2 Durables (Receivers and Transmitter)

    2. 5.2 Geography (Value and Volume, 2016 - 2026)

      1. 5.2.1 North America

        1. 5.2.1.1 United States

          1. 5.2.1.1.1 By Component

          2. 5.2.1.1.2 Coronavirus Impact on CGM Devices

        2. 5.2.1.2 Canada

          1. 5.2.1.2.1 By Component

          2. 5.2.1.2.2 Coronavirus Impact on CGM Devices

        3. 5.2.1.3 Rest of North America

          1. 5.2.1.3.1 By Component

          2. 5.2.1.3.2 Coronavirus Impact on CGM Devices

      2. 5.2.2 Europe

        1. 5.2.2.1 France

          1. 5.2.2.1.1 By Component

          2. 5.2.2.1.2 Coronavirus Impact on CGM Devices

        2. 5.2.2.2 Germany

          1. 5.2.2.2.1 By Component

          2. 5.2.2.2.2 Coronavirus Impact on CGM Devices

        3. 5.2.2.3 Italy

          1. 5.2.2.3.1 By Component

          2. 5.2.2.3.2 Coronavirus Impact on CGM Devices

        4. 5.2.2.4 Spain

          1. 5.2.2.4.1 By Component

          2. 5.2.2.4.2 Coronavirus Impact on CGM Devices

        5. 5.2.2.5 United Kingdom

          1. 5.2.2.5.1 By Component

          2. 5.2.2.5.2 Coronavirus Impact on CGM Devices

        6. 5.2.2.6 Russia

          1. 5.2.2.6.1 By Component

          2. 5.2.2.6.2 Coronavirus Impact on CGM Devices

        7. 5.2.2.7 Rest of Europe

          1. 5.2.2.7.1 By Component

          2. 5.2.2.7.2 Coronavirus Impact on CGM Devices

      3. 5.2.3 Latin America

        1. 5.2.3.1 Mexico

          1. 5.2.3.1.1 By Component

          2. 5.2.3.1.2 Coronavirus Impact on CGM Devices

        2. 5.2.3.2 Brazil

          1. 5.2.3.2.1 By Component

          2. 5.2.3.2.2 Coronavirus Impact on CGM Devices

        3. 5.2.3.3 Rest of Latin America

          1. 5.2.3.3.1 By Component

          2. 5.2.3.3.2 Coronavirus Impact on CGM Devices

      4. 5.2.4 Asia-Pacific

        1. 5.2.4.1 Japan

          1. 5.2.4.1.1 By Component

          2. 5.2.4.1.2 Coronavirus Impact on CGM Devices

        2. 5.2.4.2 South Korea

          1. 5.2.4.2.1 By Component

          2. 5.2.4.2.2 Coronavirus Impact on CGM Devices

        3. 5.2.4.3 China

          1. 5.2.4.3.1 By Component

          2. 5.2.4.3.2 Coronavirus Impact on CGM Devices

        4. 5.2.4.4 India

          1. 5.2.4.4.1 By Component

          2. 5.2.4.4.2 Coronavirus Impact on CGM Devices

        5. 5.2.4.5 Australia

          1. 5.2.4.5.1 By Component

          2. 5.2.4.5.2 Coronavirus Impact on CGM Devices

        6. 5.2.4.6 Vietnam

          1. 5.2.4.6.1 By Component

          2. 5.2.4.6.2 Coronavirus Impact on CGM Devices

        7. 5.2.4.7 Malaysia

          1. 5.2.4.7.1 By Component

          2. 5.2.4.7.2 Coronavirus Impact on CGM Devices

        8. 5.2.4.8 Indonesia

          1. 5.2.4.8.1 By Component

          2. 5.2.4.8.2 Coronavirus Impact on CGM Devices

        9. 5.2.4.9 Philippines

          1. 5.2.4.9.1 By Component

          2. 5.2.4.9.2 Coronavirus Impact on CGM Devices

        10. 5.2.4.10 Thailand

          1. 5.2.4.10.1 By Component

          2. 5.2.4.10.2 Coronavirus Impact on CGM Devices

        11. 5.2.4.11 Rest of Asia-Pacific

          1. 5.2.4.11.1 By Component

          2. 5.2.4.11.2 Coronavirus Impact on CGM Devices

      5. 5.2.5 Middle-East and Africa

        1. 5.2.5.1 Saudi Arabia

          1. 5.2.5.1.1 By Component

          2. 5.2.5.1.2 Coronavirus Impact on CGM Devices

        2. 5.2.5.2 Iran

          1. 5.2.5.2.1 By Component

          2. 5.2.5.2.2 Coronavirus Impact on CGM Devices

        3. 5.2.5.3 Egypt

          1. 5.2.5.3.1 By Component

          2. 5.2.5.3.2 Coronavirus Impact on CGM Devices

        4. 5.2.5.4 Oman

          1. 5.2.5.4.1 By Component

          2. 5.2.5.4.2 Coronavirus Impact on CGM Devices

        5. 5.2.5.5 South Africa

          1. 5.2.5.5.1 By Component

          2. 5.2.5.5.2 Coronavirus Impact on CGM Devices

        6. 5.2.5.6 Rest of Middle-East and Africa

          1. 5.2.5.6.1 By Component

          2. 5.2.5.6.2 Coronavirus Impact on CGM Devices

  6. 6. MARKET INDICATORS

    1. 6.1 Type 1 Diabetes Population (2016 - 2026)

    2. 6.2 Type 2 Diabetes Population (2016 - 2026)

  7. 7. COMPETITIVE LANDSCAPE

    1. 7.1 Company Profiles

      1. 7.1.1 Abbott Diabetes Care Inc.

      2. 7.1.2 Dexcom

      3. 7.1.3 Medtronic

    2. 7.2 Company Share Analysis

      1. 7.2.1 Abbott Diabetes Care Inc.

      2. 7.2.2 Dexcom

      3. 7.2.3 Medtronic

      4. 7.2.4 Others

  8. 8. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Continuous Glucose Monitoring (CGM) Market market is studied from 2016 - 2026.

The Continuous Glucose Monitoring (CGM) Market is growing at a CAGR of >14% over the next 5 years.

North America is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

Medtronic, Dexcom, Abbott Diabetes Care Inc., Senseonics are the major companies operating in Continuous Glucose Monitoring (CGM) Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!